MLchartDataset catalogue

hepatitis B virus antisense oligonucleotide AHB-137

Term · Oncology and biomedicine · MLC-T-ONC-014085

An unconjugated antisense oligonucleotide (ASO) targeting human hepatitis B virus (HBV), with potential antiviral activity. Upon subcutaneous administration, HBV ASO AHB-137 targets and binds to HBV messenger RNA (mRNA), thereby inhibiting the translation of HBV viral proteins. This may inhibit HBV replication.

Table 1. Record
IdentifierMLC-T-ONC-014085
FieldOncology and biomedicine
SynonymsHBV ASO AHB-137
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014085",
  "term": "hepatitis B virus antisense oligonucleotide AHB-137",
  "field": "Oncology and biomedicine",
  "definition": "An unconjugated antisense oligonucleotide (ASO) targeting human hepatitis B virus (HBV), with potential antiviral activity. Upon subcutaneous administration, HBV ASO AHB-137 targets and binds to HBV messenger RNA (mRNA), thereby inhibiting the translation of HBV viral proteins. This may inhibit HBV replication.",
  "synonyms": [
    "HBV ASO AHB-137"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hepatitis-b-virus-antisense-oligonucleotide-ahb-137/"
}

Record 8,385 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.